Pharmaceutical Technology

SEPTEMBER 14, 2022

More than 100 approved peptide-based therapeutics are currently available in the market. The increasing demand for API peptide products is in turn increasing the demand for peptide API manufacturers who also offer contract marketing services. Discover the top API protein and peptide companies in contract marketing.

Protein 100

Protein Marketing Manufacturing Reagent 100

Pharmaceutical Technology

SEPTEMBER 8, 2022

Pharmaceutical solid dose manufacturing companies in contract marketing segment have gained a vital position in pharmaceutical formulations. Find the leading pharmaceutical solid dose manufacturing companies in contract marketing. Growth of oral solid dosage contract manufacturing in the pharmaceutical industry.

Manufacturing 100

Manufacturing Marketing Contract Manufacturing Containment 100

Pharmaceutical Technology

SEPTEMBER 15, 2022

Research by GlobalData (Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition) shows that containment facilities are in high demand as the use of cytotoxic drugs continues to grow. Adding to these factors is that oncology accounts for the majority of marketed, contained drugs. Containment challenges.

Containment 130

Containment Manufacturing Production Contract Manufacturing 130

Pharmaceutical Technology

SEPTEMBER 7, 2022

The growing prevalence of chronic diseases and rising geriatric population has led to increasing demand for advanced medication adherence systems, personalised healthcare, and mobile health systems, which are the major driving factors for the patient adherence market. Discover the leading patient adherence pharmaceutical companies.

Pharmacy 130

Pharmacy Containment Manufacturing Compliance 130

Pharmaceutical Technology

SEPTEMBER 5, 2022

Wholesale pharmaceutical companies also offer services such as end formulation contracts, which help pharmaceutical marketing companies and pharmacies locate manufacturing units across regions and coordinate negotiations when required. Discover the top pharmaceutical wholesalers. Worldwide sourcing and drop-ship of orphan medicines, and.

Packaging 130

Packaging Packaging Compliance Manufacturing 130

Pharmaceutical Technology

SEPTEMBER 7, 2022

The rising incidence of long-standing diseases such as hypertension, diabetes, cardiovascular diseases, and cancer requires prolonged medication and, thus, drives the growth and need for retail pharmacies in the market. Proprietary pharmaceutical, nutraceutical, and cosmeceutical products. Prescription collection lockers.

Pharmacy 113

Pharmacy Containment Generic Drugs Production 113

XTalks

DECEMBER 8, 2021

Sweet also explored different development techniques with minimal processing. While it embodies all the properties of table sugar, Cambya contains no added sucrose or artificial additives. Growing Sugar Substitute Market. According to MarketsandMarkets , the global sugar substitute market was worth an estimated $16.5

Branding 121

Branding Manufacturing Marketing Production 121

XTalks

MAY 13, 2022

A container closure system consists of all the packaging components that contain and protect a pharmaceutical product. Container Closure Systems. A container closure system protects the product from environmental conditions, safeguarding a product’s purity, strength, safety and efficacy.

Packaging 98

Packaging Packaging Containment Production 98

pharmaphorum

OCTOBER 12, 2022

One of the biggest challenges when it comes to KOL identification and mapping is that of addressing high-growth markets and specific geographies. The example we often use from our own experience is of Multiple Sclerosis in one of the world’s largest emerging markets. Business Development Account Manager. Robert Hollands.

Marketing 52

Marketing Containment Business Development Research 52

Pharmaceutical Technology

FEBRUARY 16, 2023

The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Engineer 130

Engineer Manufacturing Containment Production 130

Pharmaceutical Technology

MAY 11, 2008

In the US solid dosage forms are distributed as containers of tablets and these can only be coded on the container and not on a per-item basis. ” Laser marking solution company Datalase has developed a system where an inactive compound can be added to the tablet formulation.

Drugs 100

Drugs Packaging Packaging Production 100

Pharmaceutical Technology

FEBRUARY 21, 2023

It took MEDELPHARM 15 years of innovation to be able to offer this high-end technology using a state-of-the-art automation and motion system,” says Quentin Boulay, product marketing manager at MEDELPHARM, the innovators of the STYL’One Evo compaction simulator. OEB level) your products necessitate.

Production 130

Production Scientist Containment Development 130

XTalks

AUGUST 16, 2023

“We knew we had the opportunity to create something special when we saw the positive response to our previous seasonal collaborations for Dunkin’-inspired beers,” said Brian Gilbert, vice president of retail business development at Dunkin’, in a press release. percent between 2022 and 2030. ounce cans.

Branding 52

Branding Containment Marketing Business Development 52

pharmaphorum

FEBRUARY 11, 2022

Sun says Komodo’s Healthcare Map has been built over the last seven and a half years and contains so much information that can help identify and treat patients with rare diseases. He oversees operations, including business development, sales and marketing, and people. ” About the interviewee.

Life Science 105

Life Science Engineer Development Big Data 105

The Pharma Data

MAY 3, 2021

The share repurchase authorizations permit shares to be repurchased in a variety of methods, including open market purchases, accelerated share repurchases, or other privately negotiated transactions. Purchases may be made from time to time at management’s discretion. To learn more about Lilly , please visit us at? www.lilly.com ?and?

Medicine 52

Medicine Containment Business Development Development 52

The Pharma Data

OCTOBER 20, 2020

MBA, as the Company’s Chief Business Officer following the retirement of Wenji Chen, PhD, MBA, from her position as Vice President of Corporate Development. I look forward to working closely with my TLC colleagues and our external partners to bring these important medicines to markets across the globe.” Source link.

Licensing 40

Licensing Licensing Drug Delivery Business Development 40

The Pharma Data

DECEMBER 23, 2020

This vaccine has immense potential in eliminating shedding, and hence containing, the spread of the pandemic.” Aurobindo Pharma and COVAXX are partnering on clinical development, manufacturing and marketing of COVAXX’s vaccine candidate, UB-612. The Company is marketing these products globally, in over 150 countries.

Vaccination 52

Vaccination Vaccine Development Manufacturing 52

The Pharma Data

JANUARY 6, 2021

This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These items are uncertain and depend on various factors that could have a material impact on GAAP net income for the guidance period. Forward-Looking Statements.

Production 52

Production Marketing Containment Sales 52

The Pharma Data

DECEMBER 17, 2020

George Yeh, President of TLC, commenced the conference and welcomed the company’s new Chief Business Officer, Mr. Tom Bliss. With experiences attained in licensing and business development functions from Amgen, Baxter and Johnson & Johnson, Mr. Bliss introduced himself in Mandarin Chinese. Source link.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Containment 40

The Pharma Data

JANUARY 12, 2021

As part of this role he built innovative, high-performing development teams and managed the Regeneron’s regulatory filings, interactions with regulatory agencies, product launches, and business development and licensing activities across its product portfolio. Previously, he held roles as CMO at Trimeris Inc.

Life Science 52

Life Science Antibody In-Vivo In-Vitro 52

The Pharma Data

NOVEMBER 3, 2020

LogicBio is developing these highly potent vectors for internal development candidates and potentially for business development collaborations. LogicBio is headquartered in Lexington, Mass. For more information, please visit www.logicbio.com. Forward Looking Statements.

Clinical Trials 40

Clinical Trials Clinical Trials Gene Editing Genome 40

The Pharma Data

NOVEMBER 5, 2020

resolving patent litigation brought in response to Teva’s Abbreviated New Drug Application, seeking approval to market a generic version of Xtampza ER prior to the expiration of Collegium’s applicable patents. This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995.

Production 52

Production Marketing Sales Manufacturing 52

The Pharma Data

OCTOBER 27, 2020

With over twenty years of topical and transdermal drug delivery experience in the pharmaceutical market, Ovation’s management and science team have created a unique pipeline of over twenty-five patent-protected medical / wellness topical and transdermal products along with a line of anti-aging / beauty formulas.

Sales 52

Sales Production Drug Delivery Development 52

The Pharma Data

MAY 18, 2021

Our Crop Science Division achieved encouraging sales growth in an improved market environment. The Fungicides business benefited from volume and price increases in the Latin America region, particularly for the product Fox Xpro™. to 1.252 billion euros in a declining market. Sales at Vegetable Seeds rose in all regions.

Sales 40

Sales Production Marketing Containment 40

The Pharma Data

NOVEMBER 10, 2020

. AlzeCure ® is a Swedish pharmaceutical company that develops new innovative drug therapies for the treatment of severe diseases and conditions that affect the central nervous system, such as Alzheimer’s disease and pain – indications for which currently available treatment is extremely limited.

Development 40

Development Drugs Protein Research 40

The Pharma Data

JANUARY 4, 2021

This press release contains forward-looking statements that involve substantial risks and uncertainties. The Company maintains offices in Houston, Texas. For more information, please visit the company’s website at www.kiromic.com. Forward-Looking Statements. relevant government policies and regulations relating to our industry.

In-Vivo 40

In-Vivo Development Immune Response Big Data 40

The Pharma Data

NOVEMBER 15, 2020

Prior to Celgene, she held leadership roles in marketing, sales and new business development from 2002 to 2011 at Johnson & Johnson. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Before that, Ms.

Clinical Trials 40

Clinical Trials Clinical Trials Production Trials 40

The Pharma Data

OCTOBER 14, 2020

About Mallinckrodt Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. Hogan Lovells is serving as counsel with respect to the Acthar ® Gel matter.

Production 40

Production Branding Development Regulation 40

Pharmaceutical Technology

SEPTEMBER 15, 2022

The increase in the production of biological drugs such as vaccines, gene and cell therapies, and monoclonal antibodies, is increasing the volume of injectable drug products in the global healthcare market. Discover the top commercial dose injectables companies in contract marketing. Factors driving the demand for injectables.

Marketing 100

Marketing Containment Production Sales 100

Pharmaceutical Technology

MARCH 10, 2023

The pharmaceutical freeze-drying systems market is expected to be driven by the integration of smarter technologies in lyophilisation methods such as electron microscopy, biochemistry, and advancement in surgeries.

Manufacturing 147

Manufacturing Production Containment Antibody 147

Pharmaceutical Technology

SEPTEMBER 6, 2022

The growing need for better pharmaceutical logistics, the rising demand for fast-track support, as well as growing adoption of telematics in pharmaceutical logistics are some of the important factors that are expected to drive the pharmaceutical logistics market. Finding the top pharmaceutical logistics and pharma supply chain companies.

Containment 147

Containment Pharmacy Life Science Production 147

The Pharma Data

AUGUST 3, 2021

Revenue growth was 12 percent when excluding effects of 2020 COVID-related stocking patterns, revenue from COVID-19 antibodies and recent business development. “We delivered strong performance this quarter, with volume-driven growth across our core business and most major geographies. on a non-GAAP basis.

Antibody 52

Antibody Sales Development Production 52

The Pharma Data

AUGUST 6, 2020

Marketing, selling and administrative expenses increased 51% to $1.6 Cash, cash equivalents and marketable debt securities were $22.2 Marketing, selling and administrative expense. Research and development expense. Gross margin as a percentage of revenue increased from 68.6% billion, or $1.63 billion, or $1.18

Production 52

Production Branding Marketing Containment 52

The Pharma Data

AUGUST 6, 2020

We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Business Development 52

Business Development Production Manufacturing Development 52

The Pharma Data

SEPTEMBER 22, 2020

We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Production 52

Production Manufacturing Vaccination Vaccine 52

The Pharma Data

FEBRUARY 22, 2021

We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments. .

Production 52

Production Manufacturing Development Vaccination 52

The Pharma Data

SEPTEMBER 11, 2020

We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Production 52

Production Manufacturing Vaccination Vaccine 52